High inpatient dose of opioid at discharge compared to home dose predicts readmission risk in sickle cell disease
Year: 2018
Type: article
Abstract: High inpatient dose of opioid at discharge compared to home dose predicts readmission risk in sickle cell diseaseTo the Editor:Vaso-occlusive crisis (VOC) is the hallmark complication of sickle cell disease (SCD), contributing to the majority of SCD-related healthcare costs in the United States. 1 Risk factors, such as prescribing nonsteroidal anti-inflammatory drugs without opioids, older age, and steroid treatment, are associated with readmissions in pediatric SCD patients, 2,3 but limited data exist in adults.4,5 Premature discharge based on pain scores, absence of primary care providers and multiple VOC-related admissions in the prior year are associated with increased risk of 30-day readmission (30-DR) in adult SCD patients.4,5 In this report, we analyzed the inpatient and ORCID
Source: American Journal of Hematology
DOI: 10.1002/ajh.25311
Institutions: University of Illinois Chicago, Jesse Brown VA Medical Center
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2897488046